Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 17.88
  • Annual Dividend & Yield 0.14 (0.15%)
  • Most Recent Dividend 0.015 on 09/23/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 29.31% ( -0.83%)
  • Historical Volatility 16.76%
  • IV Percentile 48%
  • IV Rank 38.23%
  • IV High 38.19% on 08/05/24
  • IV Low 23.81% on 08/16/24
  • Put/Call Vol Ratio 0.97
  • Today's Volume 37,915
  • Volume Avg (30-Day) 44,200
  • Put/Call OI Ratio 1.22
  • Today's Open Interest 782,914
  • Open Int (30-Day) 882,886

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.08 +3.66%
on 10/10/24
100.56 -1.99%
on 10/16/24
+0.13 (+0.13%)
since 09/27/24
3-Month
91.00 +8.31%
on 08/05/24
103.52 -4.79%
on 09/19/24
-1.71 (-1.71%)
since 07/29/24
52-Week
63.80 +54.48%
on 10/31/23
103.52 -4.79%
on 09/19/24
+34.44 (+53.71%)
since 10/27/23

Most Recent Stories

More News
Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?

After more than doubling in the past year, is this clinical-stage biotech stock still a buy?

CRBP : 16.20 (-0.86%)
$SPX : 5,832.92 (+0.16%)
NVO : 111.98 (-0.34%)
MRK : 103.73 (-0.48%)
LLY : 903.58 (+0.89%)
ABBV : 189.45 (-0.12%)
PFE : 28.46 (-1.39%)
XBI : 98.56 (+0.07%)
BMY : 52.50 (-0.27%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 9.75 (+0.52%)
LLY : 903.58 (+0.89%)
INMB : 6.30 (+2.19%)
XBI : 98.56 (+0.07%)
BIIB : 183.47 (-0.83%)
SAVA : 26.52 (-0.79%)
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

IBB : 142.42 (-0.22%)
GILD : 88.08 (-0.77%)
XBI : 98.56 (+0.07%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

REGN : 927.33 (-0.14%)
GILD : 88.08 (-0.77%)
IBB : 142.42 (-0.22%)
XBI : 98.56 (+0.07%)
SBIO : 38.93 (-0.24%)
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.

The Federal Reserve's fight against inflation may soon yield financial benefits.

XBI : 98.56 (+0.07%)
VKTX : 73.35 (-1.57%)
IOVA : 10.81 (-1.99%)
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target

The SPDR S&P Biotech ETF (XBI)  is an exchange-traded fund that tracks the biotechnology segment of the S&P Total Market Index. This ETF allows investors to gain exposure to large, mid, and small-cap...

XBI : 98.56 (+0.07%)
Earnings Preview: What to Expect From Regeneron Pharmaceuticals' Report

Regeneron Pharmaceuticals is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit increase.

REGN : 927.33 (-0.14%)
$SPX : 5,832.92 (+0.16%)
XBI : 98.56 (+0.07%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 48.41 (+0.02%)
NTLA : 14.99 (-8.26%)
PRME : 4.08 (-3.09%)
BEAM : 22.17 (-0.81%)
XBI : 98.56 (+0.07%)
WFC : 65.30 (-0.47%)
VKTX : 73.35 (-1.57%)
CRSP : 48.94 (-1.55%)
ABBV : 189.45 (-0.12%)
AMGN : 316.00 (-0.37%)
BMY : 52.50 (-0.27%)
GILD : 88.08 (-0.77%)
Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

MRNA : 55.22 (+0.77%)
$SPX : 5,832.92 (+0.16%)
XBI : 98.56 (+0.07%)
IBM : 210.43 (-1.16%)
UBS : 32.82 (+1.33%)
Regeneron Pharmaceuticals' Q1 2024 Earnings: What to Expect

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988 and focuses on inventing life-transforming medicines for people...

REGN : 927.33 (-0.14%)
$SPX : 5,832.92 (+0.16%)
XBI : 98.56 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 100.04
2nd Resistance Point 99.37
1st Resistance Point 98.97
Last Price 98.56
1st Support Level 97.90
2nd Support Level 97.23
3rd Support Level 96.83

See More

52-Week High 103.52
Last Price 98.56
Fibonacci 61.8% 88.35
Fibonacci 50% 83.66
Fibonacci 38.2% 78.97
52-Week Low 63.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar